Clinical study on reducing the malignant risk of residual lung GGN with Jiawei Xiaolong pill based on AI image judgment Technology
- Conditions
- Ground glass nodule of lung
- Registration Number
- ITMCTR2000003831
- Lead Sponsor
- onghua Hospital Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. lung surgery was performed, postoperative pathology was cancer, residual ground glass nodules, ground glass nodules met the diagnostic criteria of Western medicine, CT imaging showed ground glass nodules, the maximum diameter of nodules was less than 8 mm;
2. TCM syndrome differentiation belongs to liver stagnation and qi stagnation, spleen deficiency and phlegm dampness syndrome;
3. Aged 25 to 80 years old;
4. the course of oral Chinese medicine in outpatient department was more than 12 months, and informed consent was signed.
1. in the process of clinical study, some complications and complications occurred, which affected the efficacy and safety judgment;
2. the subjects had poor compliance and could not continue to cooperate to complete the 12-month course of treatment;
3. serious adverse reactions occurred and it was not suitable to continue the trial;
4. the subjects asked to withdraw from the trial;
5. For various reasons, the patient is unwilling to accept traditional Chinese medicine treatment;
6. The patients underwent the operation of ground glass nodule again.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chest CT;
- Secondary Outcome Measures
Name Time Method